0001225208-24-001898.txt : 20240212
0001225208-24-001898.hdr.sgml : 20240212
20240212192510
ACCESSION NUMBER: 0001225208-24-001898
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolk Joseph J
CENTRAL INDEX KEY: 0001744564
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24622071
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-02-08
0000200406
JOHNSON & JOHNSON
JNJ
0001744564
Wolk Joseph J
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
Exec VP, CFO
0
Common Stock
2024-02-08
4
M
0
3686.0000
0.0000
A
53911.0000
D
Common Stock
2024-02-08
4
F
0
1047.0000
156.3300
D
52864.0000
D
Common Stock
2048.0000
I
By 401k
Restricted Share Units
2024-02-08
4
M
0
3686.0000
0.0000
D
2024-02-08
Common Stock
3686.0000
0.0000
D
Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
Shares withheld for payment of taxes upon vesting of Restricted Share Units.
Reflects an adjustment to the total number of shares previously reported by the reporting person after a reconciliation of such person's ownership records.
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
/s/ Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
2024-02-12